Clinical Trial Update: Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

This Phase 4 trial reports on the efficacy and safety of a dual therapy regimen for Helicobacter pylori eradication, and the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED